lung cancer

Displaying 1 - 5 of 5


Linkous advances lung cancer research with Merck Research Laboratories Scientific Engagement and Emerging Discovery Science program

Vanderbilt University’s Research Associate Professor of Pharmacology, Amanda Linkous, received a research grant from the Merck Research Laboratories SEEDS program to study therapeutic intervention points for preventing lung cancer metastasis in the brain. Despite common treatments, many cases of lung cancer spread to the brain, leading to challenges in treatment. Linkous aims to use 3D organoid models and computational analyses to understand how tumor cells adapt to the brain environment.


Lung cancer survival signal

Small cell lung cancer (SCLC) represents up to 25 percent of lung cancer cell deaths and is associated with early metastasis and poor patient survival.


Team’s potential lung cancer therapy lands award from SBIR

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.


A new target for lung cancer

Recent studies have discovered a role for the transporter protein xCT in the survival of different cancer cell types including breast, glioma and lymphoma.